FCC announces $100M initiative to support telehealth programs for veterans, rural populations

On Thursday, August 2, the Federal Communications Commission unanimously approved a plan to establish a $100 million program to help establish telehealth efforts for low-income Americans, focusing particularly on rural communities and veterans.

The “Connected Care Pilot Program” will support deployment of remote patient monitoring—targeting projects over a three-year period to study costs and benefits. FCC Commission Brendan Carr cited studies showing chronic diseases can account for 85 percent of healthcare spending. Telehealth initiatives could reduce costs by remotely monitoring patients in rural areas.

“I am glad my colleagues on the commission voted to approve my proposal to begin establishing the Connected Care Pilot Program,” said Carr in a prepared statement. “The FCC has long supported broadband deployments to brick-and-mortar healthcare facilities, but advancements in technology mean we can now bring connected care everywhere. So, we should explore how the FCC can support this new trend in telehealth, which can lower costs and improve health outcomes. Low-income Americans, particularly in rural areas, face obstacles to healthcare, and I’m glad the FCC is doing its part to help bridge this doctor divide.”

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.